Merck broke ground on a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Del., the Rahway-based company announced April 29. The Merck Wilmington Biotech ...
Merck, one of the premier leaders in research-intensive biopharmaceuticals, is recognized on a global scale for its development of medicine and vaccines, including vaccines for human papillomavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results